PT-141 – Melanocortin Receptor Agonist Peptide
Product Overview
PT-141 (also known as bremelanotide) is a synthetic cyclic heptapeptide analog of the endogenous melanocortin peptide α-melanocyte-stimulating hormone (α-MSH). It acts as an agonist at melanocortin receptors, with activity reported at MC3R and MC4R, and is used in laboratory research examining melanocortin signaling pathways and receptor pharmacology.
This product is supplied as a high-purity lyophilized powder for in vitro and laboratory research applications only.
Independent Batch Testing
Each batch of PT-141 is independently verified through third-party laboratory testing to confirm chemical accuracy, purity, and sterility.
| Molecular Class | Synthetic cyclic heptapeptide, melanocortin receptor agonist |
| Synonyms | Bremelanotide |
| Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | 1025.16 g/mol |
| CAS Number | 189691-06-3 |
| Form | Lyophilized powder (White) |
Research & Handling
PT-141 is distributed exclusively for research use only. It is not approved for medical, diagnostic, therapeutic, or veterinary use. Do not introduce this compound into the human or animal body. Any use outside of research violates product terms and federal guidelines.
This research material is shipped in a lyophilized powder state and must be handled with proper lab protocols and safety measures.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Shipping & Returns
Orders ship the next business day via USPS Priority Mail. Due to the nature of this product, we do not accept returns. In rare cases of loss or damage during shipment, please contact our support team for a replacement.
Research Use Only Disclaimer
All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Amino Alchemy is a chemical supplier. Amino Alchemy is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Amino Alchemy is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.